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Zeberg et al. show that a Neanderthal
variant of the sodium channel Nav1.7,
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pain signals, occurs in some humans
today. The Neanderthal variant differs
from the common variant in its
electrophysiological properties and is
associated with increased sensitivity to
pain.nc. ll
OPEN ACCESS
Please cite this article in press as: Zeberg et al., A Neanderthal Sodium Channel Increases Pain Sensitivity in Present-Day Humans, Current Biology
(2020), https://doi.org/10.1016/j.cub.2020.06.045llReport
A Neanderthal Sodium Channel Increases
Pain Sensitivity in Present-Day Humans
Hugo Zeberg,1,2,6,* Michael Dannemann,1 Kristoffer Sahlholm,2,3 Kristin Tsuo,1 Tomislav Maricic,1 Victor Wiebe,1
Wulf Hevers,1 Hugh P.C. Robinson,2,4 Janet Kelso,1 and Svante P€a€abo1,5,*
1Max Planck Institute for Evolutionary Anthropology, Deutscher Platz 6, 04103 Leipzig, Germany
2Department of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden
3Department of Integrative Medical Biology, Wallenberg Centre for Molecular Medicine, Umea˚ University, 90187 Umea˚, Sweden
4Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK
5Okinawa Institute of Science and Technology, Onna-son, Okinawa 904-0495, Japan
6Lead Contact
*Correspondence: hugo.zeberg@ki.se (H.Z.), paabo@eva.mpg.de (S.P.)
https://doi.org/10.1016/j.cub.2020.06.045SUMMARYThe sodium channel Nav1.7 is crucial for impulse generation and conduction in peripheral pain pathways [1].
In Neanderthals, the Nav1.7 protein carried three amino acid substitutions (M932L, V991L, and D1908G) rela-
tive to modern humans. We expressed Nav1.7 proteins carrying all combinations of these substitutions and
studied their electrophysiological effects. Whereas the single amino acid substitutions do not affect the func-
tion of the ion channel, the full Neanderthal variant carrying all three substitutions, as well as the combination
of V991L with D1908G, shows reduced inactivation, suggesting that peripheral nerves weremore sensitive to
painful stimuli in Neanderthals than in modern humans. We show that, due to gene flow from Neanderthals,
the three Neanderthal substitutions are found in 0.4% of present-day Britons, where they are associated
with heightened pain sensitivity.RESULTS AND DISCUSSION
Neanderthals and their Asian relatives, Denisovans, evolved
largely separately from the ancestors of present-day humans
for about 500,000 years [2]. During that time, each group inde-
pendently accumulated genetic changes that became frequent
or fixed. However, late in their history, Neanderthals and Deniso-
vans mixed with modern humans, which resulted in many ge-
netic variants from Neanderthals and Denisovans being present
in humans today [3, 4]. As several Neanderthal genomes of high
quality are now available [2, 5, 6], it is possible to identify genetic
changes that occurred in many or most Neanderthals, investi-
gate their physiological effects, and assess their consequences
when they occur in people today.
Whereas most genetic differences between Neanderthals and
modern humans that affect gene products occur singly in genes
across the genome, genes that carry several such differences
are of particular note. One such case is the gene SCN9A, which
encodes the Nav1.7 protein, a voltage-gated sodium channel in
which all Neanderthal genomes sequenced to date carry three
amino acid substitutions relative to modern humans: M932L;
V991L; and D1908G. At these positions, extant monkeys and
apes share the modern human residues. Nav1.7 is the only ion
channel carrying amino acid substitutions in Neanderthals that
is highly expressed in peripheral nerves mediating pain sensa-
tion [7]. The channel allows for the passage of sodium ions
across the membranes of neurons in response to changes in
electrical membrane potential. In humans, loss-of-function mu-
tations of SCN9A cause insensitivity to pain [8] and anosmiaCurrent Biology 30, 1–5, Sep
This is an open access article und[9]. Gain-of-function mutations, on the other hand, are a leading
cause of idiopathic small-fiber neuropathy [1], where patients
present with sensory symptoms and pain, with pain as the domi-
nant symptom [10].
To investigate the electrophysiological effects of the three
substitutions seen in Neanderthals, we synthesized genes en-
coding the modern human and Neanderthal versions of
Nav1.7, transcribed these in vitro, and injected the mRNAs into
Xenopus laevis oocytes. We chose this system, rather than, for
example, cultured murine dorsal root ganglion cells, in order to
test the effects of the three amino acid substitutions when ex-
pressed together with relevant human subunits, which differ
from those of rodents by 5–47 amino acids. In peripheral nerve
endings, Nav1.7 forms complexes with the b3 subunit [11–13],
encoded bySCN3B, which carries no amino acid differences be-
tween Neanderthals, Denisovans, and modern humans. When
the b3 subunit is expressed together with Nav1.7 in the oocytes,
the inactivation curve of the Neanderthal ion channel is shifted by
6.1 mV toward less negative values relative to the modern hu-
man channel (Figures 1A and 1B; Table S1; p = 2.93 105; n = 26
and n = 31, respectively). This results in an increased availability
of sodium channels for activation and increased probability that
the sodium channel remains open for a longer time once acti-
vated and is expected to lower the threshold for the generation
of an action potential (see computational model; Figures S1M
and S1N).
To examine which of the amino acid substitutions mediates
the shift in the inactivation curve, we synthesized and injected
mRNAs encoding each of the three amino acid substitutionstember 7, 2020 ª 2020 The Author(s). Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Effects of Neanderthal-Derived Amino Acid Substitutions on Nav1.7 Inactivation
(A) Current traces from Xenopus laevis oocytes expressing modern human and Neanderthal (M932L+V991L+D1908G) Nav1.7 proteins together with the auxiliary
subunit Navb3. Following prepulses to three different potentials (shown as examples), currents were elicited by stepping to 0 mV (t = 0). Less negative prepulse
potentials resulted in progressively smaller currents due to channel inactivation. This inactivation ismore pronounced for themodern human than the Neanderthal
protein.
(B) Fraction of current as a function of prepulse potential for the modern human and Neanderthal channel proteins. Current amplitudes, measured at t = 10 ms,
were normalized to the largest amplitude obtained in each cell. The voltage required for half-maximal inactivation is shifted by +6.1 mV for the Neanderthal
protein.
(C) Fraction of current as a function of prepulse potential for the modern human and Neanderthal channel proteins when expressed in human embryonic kidney
(HEK) cells. Current amplitudes, measured as peak inward current, were normalized to the largest amplitude obtained in each cell. The voltage required for half-
maximal inactivation is shifted by +11.7 mV for the Neanderthal protein.
(D) Current traces from HEK cells expressing modern human and Neanderthal (M932L+V991L+D1908G) Nav1.7 proteins together with the auxiliary subunit
Navb3
(E) Fraction of current as a function of prepulse potential in Xenopus oocytes for the three single amino acid substitutions individually.
(F) Fraction of current in Xenopus oocytes as a function of prepulse potential for Nav1.7 proteins with two substitutions. The voltage required for half-maximal
inactivation is shifted by +6.2 mV for the V991L+D1908G protein. Compared to mammalian cells, the steady-state inactivation curves are shifted to the right due
to the recording temperature (10C ± 2C), the co-expression of the b3 subunit, and the use of Xenopus oocytes, as described [14–16].
Error bars represent SEM. See also Figures S1 and S2 and Table S1.
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Reportsingly (Figure S2). No single amino acid substitution had any
effect on the inactivation of the ion channel (Figure 1E; Table
S1). We next investigated the effect of the three possible com-
binations of two amino acid substitutions. Two of the combi-
nations, M932L+D1908G and M932L+V991L, had no effect
on the inactivation. However, V991L+ D1908G caused a shift
in the inactivation curve, similar to that of the three substitu-
tions (Figure 1F; Table S1; p = 2.4 3 105; n = 24). Thus, an
epistatic interaction of the two substitutions V991L and
D1908G, which are both located in the intracellular part of
the protein, is necessary to elicit the electrophysiological ef-
fects. In contrast, M932L, which is located extracellularly,
had no detectable effects. We note that the Denisovan
genome carries the D1908G substitution in a homozygous
form but lacks the other two substitutions. This suggests
that the D1908G substitution occurred in the common
ancestor of Neanderthals and Denisovans but that it may2 Current Biology 30, 1–5, September 7, 2020have had a functional effect only in Neanderthals, where
also the V991L substitution occurred.
To test whether the effects of the Neanderthal substitutions
are also seen in mammalian cells, we transfected human embry-
onic kidney (HEK) cells with vectors expressing the mRNAs en-
coding the modern human and the Neanderthal variants of
Nav1.7 and the b3 subunit. As in the oocytes, we observe a de-
polarizing shift in inactivation for the Neanderthal variant of
Nav1.7 (Figure 1C; Table S1; p = 9.1 3 103; n = 8 and n = 9,
respectively). In addition, we observe a depolarizing shift of the
activation curve (Figure S1C; Table S1; p = 1.1 3 103; n = 8
and n = 9, respectively). When investigated in a simple model
of a human peripheral nerve, the depolarizing shift in the inacti-
vation curve has an excitatory effect for suprathreshold stimuli,
even in the presence of a depolarizing shift in activation (Fig-
ure S1N). Thus, we conclude that the shifts seen in both oocytes
and HEK cells are likely to have an excitatory action.
Figure 2. Geographical Distribution and
Phylogenetic Relationships of SCN9A Vari-
ants
(A) Allele frequencies of the variant with all amino
acid substitutions (M932L+V991L+D1908G) in
1000G populations and in the UK Biobank (0.2%,
inset).
(B and C) Phylogenetic relationship between mod-
ern human DNA sequences and the corresponding
genome sequences of two Neanderthals in the two
genomic regions encompassing (B) M932L
(rs12478318) and V991L (rs4369876), and (C)
D1908G (rs3750904) are shown as unrooted
maximum likelihood trees. Roman numerals indicate
clusters of closely related DNA sequences, and their
geographical distribution is shown as pie charts. For
both genomic regions, one group of modern human
DNA sequences is most closely related to the
Neanderthal genome sequences (B: cluster III; C:
cluster IV). Altai and Vindija are archaeological sites,
here denoting one Neanderthal DNA sequence from
each site [2, 6].
See also Table S2.
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missense mutations (M932L, V991L, and D1908G) exist in pre-
sent-day humans by examining 2,535 genomes available in the
phase III 1000 Genomes (1000G) dataset (Figure 2A). We did
not find any of the three variants in the African (N = 507) and Eu-
ropean (N = 505) 1000G populations, but M932L and V991L
occur in almost perfect linkage disequilibrium (R2 = 0.99) at fre-
quencies of 0.9%–7.8% in Asia and 0.5%–23.8% in the Ameri-
cas. In addition, D1908G occurs at a frequency of 0%–17.1%
in Asia and 0.5%–52.9% in the Americas (Table S2) and tends
to be in linkage disequilibrium with M932L+V991L (R2 = 0.26).
These variants could have entered the present-day human
population from a common ancestor shared with Neanderthals
and Denisovans or by introgression from archaic hominins
when these met modern humans some 40,000–60,000 years
ago. In the latter case, the size of the archaic-like DNA segments
on which the variants sit are expected to be substantially larger
than if they were inherited from a common ancestor of the three
groups, as meiotic recombination will have had less time to
reduce their size. To estimate the size of these segments, we
identified alleles in this genomic region that are absent in the
1000G Yoruba individuals but occur in homozygous form in the
Neanderthal and/or Denisovan genomes and are likely to have
entered modern human populations from archaic hominins. We
identified one DNA segment (r2 > 0.8) of 26 kb around the
M932L and V991L substitutions carrying 14 such alleles
(chr2:167129256–167155131) and another segment (r2 > 0.8)
of 110 kb around the D1908G substitution carrying 40 such al-
leles (chr2:167017315–167126999).
Based on the sizes of the two DNA segments and their recom-
bination rates, we concluded that these variants entered the
modern human population by introgression from Neanderthals
or Denisovans, rather than being inherited from a common
ancestor of the groups (p = 0.059 for V991L and M932L; p =
7.8 3 1016 for D1908G). We estimated the phylogeneticrelationships of the two DNA segments overlapping
M932L+V991L and D1908G to the corresponding present-day
human and Neanderthal DNA segments. For both segments,
one group of present-day humanDNA sequences ismost closely
related to the Neanderthal segments (Figures 2B and 2C), and in
both instances, these DNA sequences are found in Asia and the
Americas.
The amino acid substitutions M932L and V991L have previ-
ously been associated with increased pain sensitivity and
small-fiber neuropathy in experimental and clinical studies in hu-
mans [1, 17]. To investigate whether the three introgressed
Neanderthal variants affect pain sensitivity in the general human
population, we selected 362,944 unrelated individuals of British
ancestry in the UK Biobank (UKBB) [18] who had answered
questions relating to their experience of pain (Table S3).
Although no individual was homozygous for the Neanderthal var-
iants, 1,327 individuals (0.4%) carried all three amino acid substi-
tutions in a heterozygous form. Based on their answers to 19
pain-related questions, these carriers of the three Neanderthal
substitutions had experienced one or more forms of pain more
often than non-carriers (Figure 3; p = 0.0078; adjusted for age
and sex). They also experienced more pain than carriers of
only one or two of the Neanderthal substitutions, although these
did not differ significantly from individuals carrying none of the
Neanderthal substitutions (Figure 3). No individuals with the
combination V991L and D1908G were found in the UKBB. Two
other substitutions in Nav1.7 that have previously been reported
to be associated with increased pain sensitivity are also geno-
typed in the UKBB and frequent enough to assess their pheno-
type (W1150R, n = 91,143; R185H, n = 1,369). Neither of these
are associated with an increased probability to report pain (p =
0.82 and p = 0.72, respectively), suggesting that their effects
are smaller than the Neanderthal-derived variants.
Notably, sex did not affect the extent towhich individuals in the
UKBB report pain (p = 0.84; 198,047 females; 164,897 males),Current Biology 30, 1–5, September 7, 2020 3
Figure 3. Pain Sensitivity among UK Biobank
Individuals (n = 362,944)
Odds ratios (ORs) for reporting pain among in-
dividuals carrying all three amino acid substitutions
(M932L+V991L+D1908G) and for each amino acid
substitution singly or in a combination with one other
substitution (but not all three) relative to the rest of
the UKBB individuals. No individual carried
V991L+D1908G. The low frequencies of the three
individual variants of M932L: 0.21%, V991L: 0.23%,
and D1908G: 0.29% are consistent with observa-
tions in the 1000G (0 of 100 in England and Scotland;
Table S2). Horizontal lines indicate 95% confidence
intervals. See also Figure S3 and Table S3.
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lation with reported pain between the ages of 40 and 70 (Fig-
ure S3; p = 4.63 10282). Individuals who carried the three amino
acid substitutions inherited from Neanderthals in heterozygous
form are 7% more likely to report at least one form of pain
compared to people without these substitutions. This corre-
sponds to an increase of approximately 8.5 years in terms of
pain reported. At the present time, we can only speculate about
the consequences of having these substitutions in homozygous
form, as was the case in the three Neanderthals genomes have
been sequenced to high coverage.
We note that Nav1.7 is expressed also in other cell types, for
example, olfactory neurons, raising the possibility that the sub-
stitutions studied here might have additional effects beyond
modulation of pain. However, given the electrophysiological ef-
fects of the substitutions, nociception, i.e., the input to the cen-
tral nervous system from peripheral nerves in response to harm-
ful or potentially harmful stimuli, is likely to have been higher in
Neanderthals than in modern humans. The translation of such
input into the conscious perception of pain is modulated both
at the level of the spinal cord and the brain. Thus, it is not
possible to conclude that Neanderthals necessarily experienced
more pain than modern humans do. Yet the input from Neander-
thal peripheral nerve endings would have allowed Neanderthals
to bemore sensitive to stimuli, as suggested by the observations
in present-day people heterozygous for the Neanderthal Nav1.7
variant.
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ReportSTAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
Normal Frog Ringer EcoCyte Bioscience Cat#: 1688
Modified Barths Solution EcoCyte Bioscience Cat#: 1697
Penicillin-Streptomycin Sigma-Aldrich Cat#: P4333
Sodium pyruvate Sigma-Aldrich Cat#: P2256
Dulbecco’s modified Eagle medium Sigma-Aldrich Cat#: D5796
TrypLE Express Enzyme Thermo-Fisher Cat#: 12605010
Fetal Bovine Serum Sigma-Aldrich Cat#: F7524
Critical Commercial Assays
mMESSAGE mMACHINE T7 ULTRA
Transcription Kit
Thermo-Fisher Cat#: AM1345
Deposited Data
Archaic genomes Max-Planck Institute EVA http://cdna.eva.mpg.de/neandertal
1000 genome project The International Genome
Sample Resource
http://www.internationalgenome.org/data
UK BioBank UK Biobank Limited https://www.ukbiobank.ac.uk/
GTEx gene expression The Genotype-Tissue Expression
(GTEx) project
https://gtexportal.org/home/datasets
Experimental Models: Organisms/Strains
Xenopus oocytes EcoCyte Bioscience First grade
Human embryonic kidney cells University of Cambridge HEK293T
Recombinant DNA
SCN9A (Nav1.7) cDNA GenScript Cat#: OHu22884
SCN3B (Navb3) cDNA GenScript Cat#: OHu16302
pXOOM vector Søren Olesen [19] N/A
Software and Algorithms
MATLAB MathWorks R2018a
R R Foundation ver. 3.5.3RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hugo
Zeberg (hugo.zeberg@ki.se).
Materials Availability
The plasmids encoding the Nav1.7 variants are available from the Lead Contact upon request.
Data and Code Availability
The recording software, utilizing the MATLAB Data Acquisition Toolbox, and electrophysiological data, including steady-state inac-
tivation and activation as a function of voltage, are available at https://gin.g-node.org/hugozeberg/SCN9A. Code used for this study
and raw data are available upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Xenopus laevis (EcoCyte Bioscience, Castrop-Rauxel, Germany) oocytes were kept at 12C in Modified Barth Solution, supple-
mented with 2.5 mM sodium pyruvate and 25 U/mL penicillin and 25 mg/ml streptomycin. HEK293T cells were cultured in Dulbecco’s
Modified Eagle Medium (DMEM), supplemented with 10% fetal calf serum and 100 U/ml penicillin and 0.1 mg/ml streptomycin, ate1 Current Biology 30, 1–5.e1–e4, September 7, 2020
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Report37C in a 5% carbon dioxide humidified incubator. For the human phenotypic analysis, 198,047 adult females and 164,897 adult
males from United Kingdom were included in the study (the UK Biobank).
METHOD DETAILS
Molecular biology
SCN9A (Nav1.7) and SCN3B (Navb3) cDNAs were synthesized by GenScript (Piscataway, NJ). The SCN9A construct used is the
most abundant splice isoform in dorsal root ganglia (DRG), and corresponds to the RefSeq sequence NM_002977.3, which encodes
aW at position 1150, as in themajority of modern humans, aswell as in all three high-coverage Neanderthal genomes. In contrast, the
human reference carries an R at this position seen in 13% of present-day humans (rs6746030). pXOOM [19] was used as the plasmid
backbone and all constructs were verified by sequencing. Plasmids were linearized with the restriction enzyme XhoI and transcribed
in vitro using the T7 mMessage mMachine ULTRA kit (Ambion, Austin, TX). cRNA concentration and purity were determined using a
spectrophotometer.
Oocyte injection
Stage V-VI oocytes injected using a Nanoject II Auto-Nanoliter Injector (Drummond Scientific, Broomall, PA) with 2 ng SCN9A cRNA
and (in experiments with the Navb3 subunit) 20 ng SCN3B cRNA in a volume of 50 nL RNase-free water. SCN3B was injected in
excess relative to SCN9A, in order to assure that Nav1.7 channels were complexed with Navb3 subunits. After injection, oocytes
were incubated at 12C for 4-6 days, before electrophysiological recordings.
Transfection of HEK293T cells
HEK293T cells were transfected with 2 mg of each of the two cDNA vectors using 10 mg branched polyethylenimine (25kDa) in 2 mL
of DMEM in 9.5 cm2 wells for 4 hours. Cells were harvested using TrypLE Express Enzyme, seeded in 3.5 cm dishes, and used for
voltage clamp experiments 24-48 hours post transfection.
Voltage clamp recordings in Xenopus oocytes
Experiments were performed at 10 ± 2C using a two-electrode voltage-clamp setup and either a CA-1 amplifier (Dagan, Minneap-
olis, MN), or an OC-725C amplifier (Warner Instruments, Hamden, CT). Data were acquired at 100 kHz via a NI-6221 DAQ using
custom written software in MATLAB (Mathworks, Natick, MA). External solution consisted of (in mM); 90 NaCl, 2 KCl, 1 MgCl2, 2
CaCl2, and 5 HEPES, adjusted to pH 7.2. Micropipettes were pulled from borosilicate glass capillaries (Harvard Apparatus, Holliston,
MA) and had a resistance of 0.5-1 MOhmwhen filled with 3M KCl. The bath potential was actively controlled to minimize series resis-
tance in the bath and across the bath-grounding electrode. Oocytes had an input resistance of 1.6 ± 0.9 MOhm (n = 216).
The voltage clamp protocols are shown in Figure S1A. The first 300 ms pulse from the baseline of 90 mV was used to measure
channel activation and the time constant for inactivation. Steady-state inactivation was measured by a second 0 mV pulse immedi-
ately following the first pulse, given the temperature coefficient of the fast inactivation (Q103 [20]), a 300-ms prepulse is equivalent
to 100-ms prepulse at room temperature. Membrane potential was clamped at 90 mV for 5 s between consecutive trials. Current
traces (Figure S2) were filtered after recordings using a rolling average of 100 data points. In Figure 1A, capacitive transients (time
constant of 1 ms) have been eliminated by fitting and subtracting a single exponential. For data analysis, we measured the current
amplitude at t = 10ms (into the 0-mV step), a time point at which virtually all capacitive transients had declined (0.004% of the initial
stimulation, or 2 nA, remained). For inactivation measurements, the current following a prepulse to +10 mV was taken as baseline
(Ibase; compensating for any non-inactivating currents, including leak currents) and current (I) was normalized to the maximal
observed current in that cell (Imax) according to (I-Ibase)/(Imax-Ibase). The channels were considered to have fully inactivated following
the +10 mV prepulse, based on previous work in Xenopus oocytes [14].
Activation as a function of voltage was measured as peak inward current relative to the current observed at the end of the 300 ms
into the first pulse (i.e., immediately before the second pulse to 0mV). Currents were converted to conductance using g = I(V-ErevNa).
The reversal potential ErevNa was calculated using the Nernst equation, assuming an intracellular sodium concentration of 22.5 mM
[21], yielding a reversal potential of +33.8 mV.
Data were fitted to a first (inactivation) or second-order Boltzmann equation (activation; as suggested by the Frankenhaeuser-Hux-
ley model [22]). The curves were fitted over the dynamic range of the functions (40 to 0 mV for activation and 70 to 10 mV for
inactivation). For the activation function, a fixed slope of 5.9/mV provided the overall best fit (see Figures S1D–S1G) and for the
steady-state inactivation function, 15.1/mV (Figures S1I–S1L). The numerical values of the fitted midpoint potentials are given in Ta-
ble S1.
The time-constants for inactivation were measured by fitting a single exponential between 10 and 20 ms into the 300-ms pulse, in
traces showing a current decay > 10 nA from 10 to 20 ms. Outliers were detected using the built in outlier detection in MATLAB.
Whereas the data points are experimental measurements, the bell-shaped curves in Figures S1O–S1Q are derived using a kinetic
model [23] with values from the steady-state inactivation curves.Current Biology 30, 1–5.e1–e4, September 7, 2020 e2
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HEK293T cells were analyzed at room temperature (23C) using either an Axon Multiclamp 700A or a 700B patch-clamp amplifier,
Molecular Devices, San Jose, CA. The pXOOM vector encodes an enhanced green fluorescent protein, which was excited to identify
transfected cells. The external solution consisted of (in mM); 140 NaCl, 2.5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES,
adjusted to pH 7.4 with NaOH. Patch pipette were pulled from borosilicate glass capillaries (Harvard Apparatus, Holliston, MA),
and the tip of the electrode was fire-polished. For low noise voltage-clamp recordings (Figure S2) with potassium currents blocked,
pipettes were filled with a solution, containing (mM): Cs methane sulfonate 125, CsCl 5, KCl 10, EGTA 1, 10 HEPES, 4 Mg-ATP, 0.3
GTP-Na2, 10 creatine phosphate-Na, pH adjusted to 7.3 with CsOH. Electrodes had a resistance of 4-11 MU, and the membrane
potential signal was corrected for nulling of the liquid junction potential before seal formation. Data was filtered using a low-pass filter
at 6 kHz (Bessel, 8-pole) and sampled at 20 kHz via a NI-X-series DAQ using custom software written inMATLAB (Mathworks, Natick,
MA). Recording pipettes were positioned with LM-Mini stepper-motor-controlled micromanipulators (Luigs and Neumann, Ratingen,
Germany). Cells had an input resistance of 1.5 ± 1.6 GOhm (min = 112Mohm, max = 4.5GOhm, n = 17). A P/n protocol consisting of 4
negative steps in every sweep, each 5mV and 500ms long, was used to compensate for passivemembrane properties. Capacitance
was also compensated for by the built-in capacitance correction circuit of the amplifier. In order to adjust for the effect of nonlinearity
in the background current, the P/n correction was scaled to between 30%and 100% tominimize the amplitude of the residual capac-
itance transient. The leak conductance was estimated using the current response between120 to70mV, before any activation of
the Na current.
Activation and inactivationwere investigatedwith the voltage clamp protocol shown in Figure S1A. Amplitudewasmeasured as the
peak inward current. Given that inactivation is hyperpolarized in mammalian cells, the voltage protocol spanned the range 120 mV
to +10 mV. Activation of conductance as a function of voltage was computed using the sodium equilibrium potential of +65mV. Data
were fitted over the entire range to a first (inactivation) or second-order Boltzmann equation (Figures S1C and S1H). The slopes from
the oocyte experiments provided a good fit for HEK cells andwere kept as fixed constants. The numerical values of the fittedmidpoint
potentials are given in Table S1.
Computational modeling
The effect of a 10-mV shift of activation and fast inactivation was studied using amodel of a peripheral nerve, based on voltage clamp
data from the human node of Ranvier [24] (ModelDB; accession: 261436). The model was implemented in MATLAB.
Amino-acid substitutions in Neanderthal ion channels
Fifteen voltage gated-like ion channels (CACNA1D, CACNA1H, CACNA1S, CATSPER3, CNGB1, HCN4, KCNH3, KCNK2, KCNV2,
PKD2L, SCN9A, TRPC6, TRPM1, TRPM4, and TRPV4) carry amino-acids substitutions in the three high-coverage Neanderthal ge-
nomes available. Expression data of these 15 channels in single-cell RNA sequencing data from rodent DRG [7] showed high expres-
sion of SCN9A only.
Archaic introgression
Potentially introgressed segments in and around SCN9A were identified by studying ‘‘archaic single-nucleotide polymorphisms’’
(‘‘aSNPs’’) defined as those that are homozygous ancestral in all 1,000G (phase III) Yoruba individuals [25], homozygous derived
in at least one of the Altai Neanderthal, the Vindija Neanderthal, and the Denisovan genomes [2, 6, 26], and for which the derived allele
is present in at least one non-African 1,000G individual. In addition, aSNPs were required to overlap previously identified regions of
Neanderthal introgression in present-day humans, i.e., having a Neanderthal posterior probability greater than 0.9 and a length of at
least 0.02 cM [3].
The likelihood of incomplete lineage sorting was tested using a published method [27], an age of the Altai Neanderthal based on a
mutation rate of 1.0x109 per base pair per year [28], and the local recombination rate estimate [29].
The relationships of present-day and Neanderthal DNA segments were estimated using genotype information from 1,000G (phase
III) individuals, excluding sites that weremissing in at least one individual or were heterozygous in one of the three archaic individuals.
This resulted in 727 variable positions in the regions overlapping V991L andM932L, and 2,868 variable sites in the region overlapping
D1908G. Haplotypes that had less than five differences per 10,000 base pairs to each other were clustered, resulting in six clusters
per region. Consensus sequences were generated by randomly selecting a variant at each position. Based on 100 and 363 positions
that were variable among these consensus sequences, maximum-likelihood phylogenies were constructed using the Hasegawa-
Kishino-Yano-85 model [30] with a proportion of invariable sites and a discrete-gamma distribution to account for variable substitu-
tion rates among sites.
Phenotypic consequences of Nav1.7 variants
Excluding individuals that were related, showed unusually low levels of heterozygosity, or who had substantial non-British ancestry
left 362,944 of 487,409 individuals from the UK Biobank [18], which were used for subsequent analysis. All combinations of the three
variants were tested for correlations with the 19 pain phenotypes and additionally with a composite binary measure that reflects
whether an individual was positive for at least one of the 19 pain-related phenotypes (Table S3). Correlations between genotypes
and pain phenotypes were assessed using logistic regression, including sex and age as co-factors in the linear model. Whereas
the primary analysis involving the composite pain measure for the Neanderthal Nav1.7 variant rejected the null hypothesis, nonee3 Current Biology 30, 1–5.e1–e4, September 7, 2020
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Reportof the other secondary analyses resulted in a p value < 0.05, and hence these p values were not adjusted for multiple comparisons.
The potential impact of noncoding aSNPswas identified using the Variant Effect Predictor [31, 32]. Identified noncoding variants were
then checked for expression changes in 48 GTEx tissues [33].
QUANTIFICATION AND STATISTICAL ANALYSIS
Oocytes were randomly selected for injection of different mRNA transcripts. Each oocyte was used only once (n = 216). HEK cells
were selected based on expression of GFP (n = 17). For the electrophysiology recordings, data were collected until the SEM of
the midpoint potentials of the steady-state activation and inactivation curves were less than ± 1.5mV. Recordings from oocytes
that had a holding current greater than 5 mA at 90mV were excluded. HEK cells were excluded if they had a leak current larger
than 500 pA at120mV, did not display a Na current (an inward current at20mVwith a peak around 1-2ms), displayed other inward
ion current fractions, or showed an atypical current-voltage relationship [34, 35] due to suboptimal recording conditions (sum of
square errors > 0.05 of the fit of a standard first-order Boltzmann curve to the inactivation process). The significance of any difference
in the midpoint potentials was determined using a two-tailed t test with n-2 degrees of freedom, corrected for multiple comparisons
using Bonferroni correction. The normality of midpoint potentials was verified using the Shapiro-Wilk test.
ADDITIONAL RESOURCES
The archaic genomes are available at http://cdna.eva.mpg.de/neandertal/. The genomes from the 1000 Genomes Project are avail-
able at http://www.internationalgenome.org/data. TheUKBioBank is available at https://www.ukbiobank.ac.uk/. GTEx gene expres-
sion data is available at https://gtexportal.org/home/datasets.Current Biology 30, 1–5.e1–e4, September 7, 2020 e4
